ONCOGENE TRANSFORMATION FREQUENCY OF NONSENESCENT SFME CELLS IS INCREASED BY C-MYC

被引:0
|
作者
RAWSON, C [1 ]
SHIRAHATA, S [1 ]
COLLODI, P [1 ]
NATSUNO, T [1 ]
BARNES, D [1 ]
机构
[1] OREGON STATE UNIV,ENVIRONM HLTH SCI CTR,DEPT BIOCHEM & BIOPHYS,CORVALLIS,OR 97331
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immortalized, postcrisis mouse embryo cell cultures derived in serum-containing medium display genomic abnormalities and an altered, preneoplastic phenotype. These lines can be transformed with single oncogenes, such as Ha-ras, while efficient transformation of precrisis, genomically unaltered rodent embryo cultures require cooperating oncogenes, such as Ha-ras and the mouse c-myc gene constitutively expressed. Serum-free mouse embryo (SFME) cells, cultured under conditions in which serum is replaced by growth factors and other supplements, are 'immortalized' in the genomically unaltered state. SFME cells do not exhibit growth crisis or gross chromosomal aberration, and are dependent on epidermal growth factor for survival, growth inhibited by serum, and are nontumorigenic. Transformation of SFME cells can be achieved with ras alone, but the introduction of c-myc increased the transfection frequency upon subsequent transfection with ras by as much as twenty fold. Similar results were obtained with mutationally activated neu oncogene and with genomic human tumor DNA. Constitutive expression of c-myc alone did not alter the properties of the SFME cells. These results demonstrate that c-myc alters cellular responses to oncogenes in a culture system in which oncogene-induced immortalization is not a factor, indicating that the effects of myc may extend beyond an 'immortalization' function in these cells.
引用
收藏
页码:487 / 489
页数:3
相关论文
共 50 条
  • [41] EXPRESSION OF C-MYC ONCOGENE IN MUCINOUS OVARIAN NEOPLASMS
    POLACARZ, SV
    HEY, NA
    JOURNAL OF PATHOLOGY, 1988, 154 (01): : A80 - A80
  • [42] C-MYC ONCOGENE EXPRESSION IN THE DYSPLASTIC AND MALIGNANT ENDOCERVIX
    POLACARZ, SV
    DAME, J
    SHERIDAN, EG
    GINSBERG, R
    SHARPE, F
    JOURNAL OF PATHOLOGY, 1990, 160 (02): : A167 - A167
  • [43] HUMAN CELLULAR ONCOGENE C-MYC AMPLIFIED IN TRYPANOSOMES
    RIOU, GF
    BARROIS, M
    JOURNAL OF PROTOZOOLOGY, 1984, 31 (04): : A75 - A76
  • [44] EXPRESSION OF C-MYC ONCOGENE IN CELIAC-DISEASE
    CICLITIRA, PJ
    STEWART, J
    EVAN, G
    WIGHT, DGD
    SIKORA, K
    JOURNAL OF CLINICAL PATHOLOGY, 1987, 40 (03) : 307 - 311
  • [45] Expression of c-Myc oncogene in sinonasal cancer.
    Bazak, Ramon
    Raha, Sumita
    Elwany, Samy
    Salam, Seddik Abdo
    Paunesku, Tatjana
    Woloschak, Gayle
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [46] C-MYC ONCOGENE EXPRESSION IN COLORECTAL-CANCER
    SIKORA, K
    CHAN, S
    EVAN, G
    GABRA, H
    MARKHAM, N
    STEWART, J
    WATSON, J
    CANCER, 1987, 59 (07) : 1289 - 1295
  • [47] DETECTION OF THE C-MYC ONCOGENE PRODUCT IN TESTICULAR CANCER
    SIKORA, K
    EVAN, G
    STEWART, J
    WATSON, JV
    BRITISH JOURNAL OF CANCER, 1985, 52 (02) : 171 - 176
  • [48] C-MYC ONCOGENE ALTERATIONS IN HUMAN THYROID CARCINOMAS
    DELSENNO, L
    UBERTI, ED
    BERNARDI, F
    MARCHETTI, G
    PERROTTA, C
    GAMBARI, R
    BARBIERI, R
    BUZZONI, D
    PANSINI, G
    CONCONI, F
    CANCER DETECTION AND PREVENTION, 1987, 10 (3-4): : 159 - 166
  • [49] Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro
    Tselepis, C
    Morris, CD
    Wakelin, D
    Hardy, R
    Perry, I
    Luong, QT
    Harper, E
    Harrison, R
    Attwood, SEA
    Jankowski, JAZ
    GUT, 2003, 52 (02) : 174 - 180
  • [50] THE VIRAL ONCOGENE V-MYC AND THE CELLULAR PROTONIC GENE C-MYC
    JANSEN, HW
    PATSCHINSKY, T
    BISTER, K
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1983, 105 (02) : A44 - A44